| NCT04452305 |
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting |
https://ClinicalTrials.gov/show/NCT04452305 |
Recruiting |
University of Pittsburgh |
2025-07-01 |
| NCT03370627 |
Effect of Anti-CD303 Antibodies in Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT03370627 |
Recruiting |
University Hospital, Lille |
2020-01-31 |
| NCT03345004 |
GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT03345004 |
Active, not recruiting |
Diamyd Medical AB |
2020-08-31 |
| NCT03342495 |
Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial |
https://ClinicalTrials.gov/show/NCT03342495 |
Recruiting |
University of Calgary |
2019-12-31 |
| NCT03337165 |
Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT03337165 |
Completed |
Russian Academy of Medical Sciences |
2019-05-31 |
| NCT03280797 |
Feasibility of a Cytokine Expression Profile in Immune Cells as an Orientation Tool in Therapeutic Decisions for Auto-inflammatory and Auto-immune Diseases |
https://ClinicalTrials.gov/show/NCT03280797 |
Recruiting |
Centre Hospitalier Universitaire de Nīmes |
2020-11-30 |
| NCT03266172 |
A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses |
https://ClinicalTrials.gov/show/NCT03266172 |
Completed |
GlaxoSmithKline |
2018-11-21 |
| NCT03231033 |
Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis |
https://ClinicalTrials.gov/show/NCT03231033 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2019-04-02 |
| NCT03186794 |
Aerobic Exercise in Women With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03186794 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-31 |
| NCT03122431 |
Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT03122431 |
Recruiting |
University of Sao Paulo General Hospital |
2020-06-01 |
| NCT03044873 |
Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin |
https://ClinicalTrials.gov/show/NCT03044873 |
Completed |
Bristol-Myers Squibb |
2017-03-14 |
| NCT03006146 |
Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis |
https://ClinicalTrials.gov/show/NCT03006146 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-12-31 |
| NCT02985190 |
A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders |
https://ClinicalTrials.gov/show/NCT02985190 |
Active, not recruiting |
Groupe Francophone des Myelodysplasies |
2021-07-31 |
| NCT02972801 |
Testicular Tissue Cryopreservation for Fertility Preservation |
https://ClinicalTrials.gov/show/NCT02972801 |
Recruiting |
University of Pittsburgh |
2021-01-31 |
| NCT02925351 |
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases |
https://ClinicalTrials.gov/show/NCT02925351 |
Completed |
Jonsson Comprehensive Cancer Center |
2018-04-30 |
| NCT02899377 |
A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts |
https://ClinicalTrials.gov/show/NCT02899377 |
Completed |
GlaxoSmithKline |
2018-07-12 |
| NCT02862301 |
Epigenetic Evaluation of HAT/HDAC Activity in PBMC From Patients With Clinically Isolated Syndrome |
https://ClinicalTrials.gov/show/NCT02862301 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2020-06-30 |
| NCT02824393 |
Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria |
https://ClinicalTrials.gov/show/NCT02824393 |
Completed |
Celal Bayar University |
2018-05-15 |
| NCT02780674 |
A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT02780674 |
Completed |
Viela Bio |
2017-10-23 |
| NCT02702180 |
Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) |
https://ClinicalTrials.gov/show/NCT02702180 |
Completed |
Savara Inc. |
2019-04-19 |
| NCT02682511 |
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT02682511 |
Recruiting |
Cumberland Pharmaceuticals |
2020-12-31 |
| NCT02647866 |
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis |
https://ClinicalTrials.gov/show/NCT02647866 |
Completed |
Kyowa Kirin Pharmaceutical Development, Inc. |
2018-09-30 |
| NCT02644759 |
Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT02644759 |
Completed |
Stem Cells Arabia |
2017-08-31 |
| NCT02602977 |
the Influence of Remote Ischemic Preconditioning on Inflammation During Human Endotoxemia |
https://ClinicalTrials.gov/show/NCT02602977 |
Completed |
Radboud University |
2016-03-31 |
| NCT02523131 |
Home Testing of Day and Night Closed Loop With Pump Suspend Feature |
https://ClinicalTrials.gov/show/NCT02523131 |
Completed |
University of Cambridge |
2018-03-31 |
| NCT02510092 |
Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment |
https://ClinicalTrials.gov/show/NCT02510092 |
Active, not recruiting |
Semmelweis University Heart and Vascular Center |
2020-07-31 |
| NCT02449746 |
Study of Immunotherapy in Autoantibody Positive Psychosis |
https://ClinicalTrials.gov/show/NCT02449746 |
Completed |
University of Cambridge |
2017-08-31 |
| NCT02421276 |
Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome |
https://ClinicalTrials.gov/show/NCT02421276 |
Recruiting |
University of Colorado, Denver |
2020-01-31 |
| NCT02417155 |
Increasing Plasma Adrenaline Levels Through Breathing Techniques - an Explorative Study |
https://ClinicalTrials.gov/show/NCT02417155 |
Completed |
Radboud University |
2015-07-31 |
| NCT02293161 |
Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02293161 |
Completed |
GlaxoSmithKline |
2015-09-01 |
| NCT02280434 |
Phase 1 Study Accessing the Safety and Tolerability of CBP-307 |
https://ClinicalTrials.gov/show/NCT02280434 |
Completed |
Suzhou Connect Biopharmaceuticals, Ltd. |
2015-08-31 |
| NCT02263703 |
Immunogenicity of HPV Vaccine in Immunosuppressed Children |
https://ClinicalTrials.gov/show/NCT02263703 |
Completed |
The University of New South Wales |
2016-02-29 |
| NCT02261688 |
Salt and TH-17 in Healthy Human Subjects |
https://ClinicalTrials.gov/show/NCT02261688 |
Completed |
Brigham and Women’s Hospital |
2019-07-31 |
| NCT02129868 |
Automated Closed-loop in Children and Adolescents With Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT02129868 |
Completed |
University of Cambridge |
2015-04-30 |
| NCT01281969 |
Intravenous Immunoglobulin for PANDAS |
https://ClinicalTrials.gov/show/NCT01281969 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-12-31 |
| NCT01993732 |
Ovarian Tissue Cryopreservation in Females Undergoing Procedures That Will Potentially Lead To Loss of Ovarian Function |
https://ClinicalTrials.gov/show/NCT01993732 |
Completed |
Medical College of Wisconsin |
2018-06-28 |
| NCT01953523 |
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions |
https://ClinicalTrials.gov/show/NCT01953523 |
Completed |
Cell Surgical Network Inc. |
2016-12-31 |
| NCT01932476 |
Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes |
https://ClinicalTrials.gov/show/NCT01932476 |
Completed |
Joslin Diabetes Center |
2014-12-31 |
| NCT01835457 |
Concentration/Meditation Limits Inflammation |
https://ClinicalTrials.gov/show/NCT01835457 |
Completed |
Radboud University |
2013-06-30 |
| NCT01778348 |
Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting |
https://ClinicalTrials.gov/show/NCT01778348 |
Completed |
University of Cambridge |
2015-03-31 |
| NCT01764594 |
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01764594 |
Completed |
UCB Pharma |
2014-08-31 |
| NCT01758042 |
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders |
https://ClinicalTrials.gov/show/NCT01758042 |
Recruiting |
Massachusetts General Hospital |
2019-07-31 |
| NCT01735123 |
Early Dietary Intervention and Later Signs of Beta-Cell Autoimmunity |
https://ClinicalTrials.gov/show/NCT01735123 |
Completed |
University of Helsinki |
2016-07-31 |
| NCT01727973 |
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves’ Orbitopathy |
https://ClinicalTrials.gov/show/NCT01727973 |
Completed |
Sun Yat-sen University |
2013-11-30 |
| NCT01684761 |
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01684761 |
Completed |
Opexa Therapeutics, Inc. |
2016-10-31 |
| NCT01656278 |
An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT01656278 |
Completed |
King Christian X´Hospital for Rheumatic Diseases |
2017-05-31 |
| NCT01601028 |
Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren’s Syndrome |
https://ClinicalTrials.gov/show/NCT01601028 |
Completed |
Seoul National University Hospital |
2013-08-31 |
| NCT01582880 |
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis |
https://ClinicalTrials.gov/show/NCT01582880 |
Completed |
Massachusetts Eye and Ear Infirmary |
2014-03-31 |
| NCT01527383 |
A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009) |
https://ClinicalTrials.gov/show/NCT01527383 |
Completed |
Merck Sharp & Dohme Corp. |
2013-02-26 |
| NCT01420133 |
Is a Diet Necessary When Corticosteroid Treatment is Prescribed? |
https://ClinicalTrials.gov/show/NCT01420133 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2015-10-31 |
| NCT01416350 |
A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin |
https://ClinicalTrials.gov/show/NCT01416350 |
Completed |
GlaxoSmithKline |
2011-05-12 |
| NCT01351805 |
Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain |
https://ClinicalTrials.gov/show/NCT01351805 |
Active, not recruiting |
Brigham and Women’s Hospital |
2022-04-30 |
| NCT04274257 |
A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT04274257 |
Completed |
Tokyo University |
2019-05-09 |
| NCT04186871 |
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren’s Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT04186871 |
Recruiting |
Bristol-Myers Squibb |
2022-06-23 |
| NCT04127747 |
Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT04127747 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2022-12-31 |
| NCT04041544 |
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject |
https://ClinicalTrials.gov/show/NCT04041544 |
Recruiting |
SinoMab Pty Ltd |
2020-07-31 |
| NCT04005456 |
Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design |
https://ClinicalTrials.gov/show/NCT04005456 |
Recruiting |
Metagenics, Inc. |
2020-08-31 |
| NCT03971487 |
Ocrelizumab for Psychosis by Autoimmunity |
https://ClinicalTrials.gov/show/NCT03971487 |
Recruiting |
The Methodist Hospital System |
2021-03-31 |
| NCT03956953 |
Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese Subjects |
https://ClinicalTrials.gov/show/NCT03956953 |
Completed |
Bristol-Myers Squibb |
2019-09-25 |
| NCT03907540 |
Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025 |
https://ClinicalTrials.gov/show/NCT03907540 |
Completed |
Kadmon Corporation, LLC |
2019-05-20 |
| NCT03849131 |
Patient-Reported AutoImmunity Secondary to Cancer immunothErapy |
https://ClinicalTrials.gov/show/NCT03849131 |
Recruiting |
University Hospital, Strasbourg, France |
2026-11-30 |
| NCT03816345 |
Nivolumab in Treating Patients With Autoimmune Disorders or Advanced, Metastatic, or Unresectable Cancer |
https://ClinicalTrials.gov/show/NCT03816345 |
Recruiting |
National Cancer Institute (NCI) |
2022-08-31 |
| NCT03782636 |
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD) |
https://ClinicalTrials.gov/show/NCT03782636 |
Recruiting |
University of Oxford |
2022-04-14 |
| NCT03715699 |
Leflunomide Treatment for IgG4-RD |
https://ClinicalTrials.gov/show/NCT03715699 |
Recruiting |
Peking Union Medical College Hospital |
2020-12-31 |
| NCT03656627 |
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease |
https://ClinicalTrials.gov/show/NCT03656627 |
Recruiting |
Alliance Foundation Trials, LLC. |
2022-10-31 |
| NCT03649412 |
A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772 |
https://ClinicalTrials.gov/show/NCT03649412 |
Completed |
GlaxoSmithKline |
2019-05-07 |
| NCT03644069 |
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) |
https://ClinicalTrials.gov/show/NCT03644069 |
Active, not recruiting |
ImmusanT, Inc. |
2019-09-30 |
| NCT03590613 |
Phase I Study of GSK2982772 in Japanese Healthy Male Participants |
https://ClinicalTrials.gov/show/NCT03590613 |
Completed |
GlaxoSmithKline |
2018-09-21 |
| NCT03540485 |
Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis |
https://ClinicalTrials.gov/show/NCT03540485 |
Recruiting |
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
2020-07-31 |
| NCT03530995 |
Drug-drug Interaction Study Between KD025, Itraconazole, Rifampicin, Rabeprazole and Omeprazole in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03530995 |
Completed |
Kadmon Corporation, LLC |
2019-03-15 |
| NCT03482752 |
Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis |
https://ClinicalTrials.gov/show/NCT03482752 |
Enrolling by invitation |
Savara Inc. |
2021-12-31 |
| NCT01210716 |
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device |
https://ClinicalTrials.gov/show/NCT01210716 |
Completed |
Fenwal, Inc. |
2011-05-31 |
| NCT01205438 |
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01205438 |
Completed |
Eli Lilly and Company |
2014-08-31 |
| NCT01196091 |
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT01196091 |
Completed |
Eli Lilly and Company |
2014-07-31 |
| NCT01093911 |
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) |
https://ClinicalTrials.gov/show/NCT01093911 |
Completed |
UCB Pharma |
2012-12-31 |
| NCT01086631 |
Rituximab for Autoimmune Retinopathy |
https://ClinicalTrials.gov/show/NCT01086631 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01065285 |
Vaccination Against Influenza in Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT01065285 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2011-07-31 |
| NCT01056471 |
Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis |
https://ClinicalTrials.gov/show/NCT01056471 |
Completed |
Andalusian Network for Design and Translation of Advanced Therapies |
2012-06-30 |
| NCT01055080 |
Insulin-free Cow Milk Formula in Prevention of Type 1 Diabetes Associated Autoimmunity - FINDIA Pilot Study |
https://ClinicalTrials.gov/show/NCT01055080 |
Completed |
National Institute for Health and Welfare, Finland |
2006-06-30 |
| NCT01004432 |
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) |
https://ClinicalTrials.gov/show/NCT01004432 |
Completed |
Janssen Biotech, Inc. |
2013-07-31 |
| NCT00977977 |
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy |
https://ClinicalTrials.gov/show/NCT00977977 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-01-01 |
| NCT00975936 |
Phase 0 Microdose Study |
https://ClinicalTrials.gov/show/NCT00975936 |
Completed |
GlaxoSmithKline |
2009-11-12 |
| NCT00931489 |
Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) |
https://ClinicalTrials.gov/show/NCT00931489 |
Completed |
University of California, Davis |
2014-06-30 |
| NCT03305419 |
A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03305419 |
Completed |
GlaxoSmithKline |
2018-10-15 |
| NCT00815282 |
Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease |
https://ClinicalTrials.gov/show/NCT00815282 |
Completed |
UMC Utrecht |
2015-01-31 |
| NCT02925299 |
Day and Night Closed-loop in Young People With Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT02925299 |
Active, not recruiting |
Jaeb Center for Health Research |
2020-06-30 |
| NCT02219256 |
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants |
https://ClinicalTrials.gov/show/NCT02219256 |
Completed |
Takeda |
2016-04-30 |
| NCT02040116 |
Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT02040116 |
Completed |
Wake Forest University Health Sciences |
2014-08-31 |
| NCT00716066 |
Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT00716066 |
Recruiting |
Fred Hutchinson Cancer Research Center |
2026-03-31 |
| NCT00419419 |
Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud’s Phenomenon |
https://ClinicalTrials.gov/show/NCT00419419 |
Completed |
MediQuest Therapeutics |
NA |
| NCT00820469 |
Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab |
https://ClinicalTrials.gov/show/NCT00820469 |
Completed |
University Hospital, Toulouse |
2009-11-30 |
| NCT00378521 |
Dose Response Study of a Topical Gel for the Treatment of Raynaud’s Phenomenon |
https://ClinicalTrials.gov/show/NCT00378521 |
Completed |
MediQuest Therapeutics |
NA |
| NCT00372177 |
The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis |
https://ClinicalTrials.gov/show/NCT00372177 |
Completed |
Biotectid GmbH |
2008-05-31 |
| NCT00351377 |
Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate |
https://ClinicalTrials.gov/show/NCT00351377 |
Completed |
Novartis |
2009-06-30 |
| NCT00304291 |
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) |
https://ClinicalTrials.gov/show/NCT00304291 |
Completed |
State University of New York at Buffalo |
NA |
| NCT00253331 |
Lab Study of MQX-503 in Treatment of Raynaud’s |
https://ClinicalTrials.gov/show/NCT00253331 |
Completed |
MediQuest Therapeutics |
NA |
| NCT00114530 |
Scleroderma: Cyclophosphamide or Transplantation (SCOT) |
https://ClinicalTrials.gov/show/NCT00114530 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-04-30 |
| NCT00065390 |
Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome |
https://ClinicalTrials.gov/show/NCT00065390 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001768 |
Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) |
https://ClinicalTrials.gov/show/NCT00001768 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001658 |
Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections |
https://ClinicalTrials.gov/show/NCT00001658 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00039988 |
Treatment of Multiple Sclerosis With Copaxone and Albuterol |
https://ClinicalTrials.gov/show/NCT00039988 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-03-31 |
| NCT00035308 |
Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease |
https://ClinicalTrials.gov/show/NCT00035308 |
Completed |
La Jolla Pharmaceutical Company |
NA |
| NCT00817752 |
Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation |
https://ClinicalTrials.gov/show/NCT00817752 |
Completed |
National University of Natural Medicine |
2008-01-31 |
| NCT00010387 |
Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease |
https://ClinicalTrials.gov/show/NCT00010387 |
Completed |
Office of Rare Diseases (ORD) |
2007-08-31 |
| NCT00010335 |
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders |
https://ClinicalTrials.gov/show/NCT00010335 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-07-31 |
| NCT00001630 |
Treatment of Autoimmune Thrombocytopenia (AITP) |
https://ClinicalTrials.gov/show/NCT00001630 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00013689 |
Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome |
https://ClinicalTrials.gov/show/NCT00013689 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |